In three consecutive articles published in On The Risk throughout 2025, Munich Re Life documented the effectiveness of EHR data in more than 800 underwriting cases across multiple carriers and every major evidence scenario. It’s the most comprehensive independent validation to date—and the findings are clear: EHR data reduces underwriting time and cost.
In a digital world, people are increasingly concerned about data privacy. The pharmaceutical industry is no exception. The growing importance of data privacy requires companies to prioritize effective patient consent and preference management. Personalized medicine, electronic health records, and an...
Patient recruitment remains a critical challenge in clinical trials, with up to 80% of studies failing to meet enrollment timelines, causing costly delays. With the data revolution transforming the healthcare industry, it seemed that clinical trials would see a new...
